Investors

At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders

Q3 2019 Investor Presentation

Download

2018 Annual Report to Stockholders

Download

Learn More

Upcoming Events

More events are coming soon.

Recent News

February 26, 2020

Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results; Updates Full Year 2020 Financial Outlook

2019 Revenue Increased 32% Year-Over-Year; Fourth Quarter Revenue Increased 23% Year-Over-Year MINNEAPOLIS , Feb. 26, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the at-home

February 24, 2020

Tactile Medical Announces Update to Qui Tam Complaint

MINNEAPOLIS , Feb. 24, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, announced today that the Company’s motion to dismiss the qui tam

February 13, 2020

Tactile Medical Announces New Clinical Publication Highlighting the Role of Chronic Venous Insufficiency in Causing Lower Extremity Lymphedema

Researchers concluded that Chronic Venous Insufficiency, not cancer-related therapy, may be the most common cause of Lower Extremity Lymphedema in the United States, with an estimated prevalence of 16 million individuals MINNEAPOLIS , Feb. 13, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology,

February 5, 2020

Tactile Medical to Release Fourth Quarter and Fiscal Year 2019 Financial Results on February 26, 2020

MINNEAPOLIS , Feb. 05, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that fourth quarter and fiscal year 2019 financial

View All News »